Old West Investment Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Old West Investment Management’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-64,469	Closed	-$345K	–	76
2019 Q1	$345K	Buy	64,469 +20,768	+48%	+$134K	0.12%	61
2018 Q4	$224K	Sell	43,701 -1,626	-4%	-$12.3K	0.06%	65
2018 Q3	$439K	Sell	45,327 -100	-0.2%	-$1.01K	0.18%	66
2018 Q2	$463K	Buy	45,427 +17,071	+60%	+$193K	0.23%	62
2018 Q1	$368K	Buy	+28,356	New	+$422K	0.21%	66

Other funds holding PRTK

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Old West Investment Management's PRTK Position: Q2 2019 in Review

Old West Investment Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2019, closing a stake of 64,469 shares — an estimated $345K sold.

Old West Investment Management first reported a position in PRTK in Q1 2018 and held it in 5 quarters. The position peaked at $463K in Q2 2018. 89 funds tracked by Wall St. Rank hold PRTK as of Q2 2019.

Old West Investment Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Old West Investment Management sold 64,469 Paratek Pharmaceuticals, Inc. shares in Q2 2019, an estimated $345K.
Old West Investment Management first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2018 and held it in 5 quarters.
Old West Investment Management's Paratek Pharmaceuticals, Inc. position peaked at $463K in Q2 2018.
89 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2019.

Based on Old West Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.